CJ-21,058, a New SecA Inhibitor Isolated from a Fungus
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-01-25
著者
-
Suzuki Y
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Kim Y
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Kojima Yasuhiro
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Kim Yoon
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Dib-haji Fadia
Pgrd Groton Laboratories Pfizer Inc.
-
Sutcliffe Joyce
Infectious Diseses Research Pfizer Global Research And Development(pgrd)-groton Laboratories Pfizer
-
Saito Toshiyuki
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Suzuki Yumiko
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Pang C‐h
Pfizer Pharmaceuticals Inc. Aichi Jpn
-
Pang Chang-hong
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
SUGIE Yutaka
Exploratory Medicinal Sciences, PGRD, Nagoya Laboratories, Pfizer Pharmaceuticals, Inc.
-
INAGAKI Sae
Exploratory Medicinal Sciences, PGRD, Nagoya Laboratories, Pfizer Pharmaceuticals, Inc.
-
KATO Yoshinao
Exploratory Medicinal Sciences, PGRD, Nagoya Laboratories, Pfizer Pharmaceuticals, Inc.
-
NISHIDA Hiroyuki
Exploratory Medicinal Sciences, PGRD, Nagoya Laboratories, Pfizer Pharmaceuticals, Inc.
-
SAKEMI Shinichi
Exploratory Medicinal Sciences, PGRD, Nagoya Laboratories, Pfizer Pharmaceuticals, Inc.
-
DIB-HAJI Fadia
PGRD, Groton Laboratories, Pfizer Inc.
-
MUELLER John
PGRD, Groton Laboratories, Pfizer Inc.
-
SUTCLEFFE Joyce
PGRD, Groton Laboratories, Pfizer Inc.
-
Saito Tatsuhiro
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Nishida H
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Kato Yoshinao
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Mueller John
Pgrd Groton Laboratories Pfizer Inc.
-
Sujaku Tetsujo
Exploratory Medicinal Sciences And Discovery Pharmacology I Pgrd Nagoya Laboratories Pfizer Pharmace
-
Sakemi Shinichi
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Inagaki Sae
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Sugie Yutaka
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Shiomi Yukio
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Sakakibara Tatsuo
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
-
Saito Toshiyuki
Exploratory Medicinal Sciences And Discovery Pharmacology I Pgrd Nagoya Laboratories Pfizer Pharmace
-
Sakemi Shinichi
Central Research Division Pfizer Pharmaceuticals Inc.
-
Kato Yoshinao
Exploratory Medicinal Sciences Pfizer Global Research And Development(pgrd)-nagoya Laboratories Pfiz
-
Kim Yoon-jeong
Exploratory Medicinal Sciences Pgrd Nagoya Laboratories Pfizer Pharmaceuticals Inc.
関連論文
- Towards Structural Determination of the ComX Pheromone : Synthetic Studies on Peptides Containing Geranyltryptophan
- Construction of a single Component Producer from the Wild Type Avermectin Producer Streptomyces avermitilis
- Direct Production of 5-Oxo Derivatives of Avermectins by a Recombinant Strain of Streptomyces avermitilis
- Terpendoles, Novel ACAT Inhibitors Produced by Albophoma yamanashiensis II.Structure Elucidation of Terpendoles A, B, C and D
- Terpendoles, Novel ACAT Inhibitors Produced by Albophoma yamanashiensis I.Production, Isolation and Biological Properties
- Fredericamycin A Affects Mitochondrial Inheritance and Morphology in Saccharomyces cerevisiae
- Construction of a Bacterial Artificial Chromosome Library for a Myxobacterium of the Genus Cystobacter and Characterization of an Antibiotic Biosynthetic Gene Cluster
- Biotransformation of Cystothiazole A, a Myxobacterial Antibiotic, into Novel Derivatives by the Mother Producer, Cystobacter fuscus
- Biosynthetic Studies on a Myxobacterial Antibiotic, Cystothaiazole A: Biosynthetic Precursors of the Carbon Skeleton
- New Cyclic Depsipeptide Antibiotics, Clavariopsins A and B, Produced by an Aquatic Hyphomycetes, Clavariopsis aquatica : 2. Structure Analysis
- New Cyclic Depsipeptide Antibiotics, Clavariopsins A and B, Produced by an Aquatic Hyphomycetes, Clavariopsis aquatica : 1. Taxonomy, Fermentation, Isolation, and Biological Properties
- Cystothiazoles A and B, New Bithiazole-type Antibiotics from the Myxobacterium Cystobacter fuscus
- CJ-21,058, a New SecA Inhibitor Isolated from a Fungus
- CJ-15,801, a Novel Antibiotic from a Fungus, Seimatosporium sp.
- New Pyrrolizidinone Antibiotics CJ-16,264 and CJ-16,367
- A Novel Antibiotic CJ-17,572 from a Fungus, Pezicula sp.
- A New Antibiotic CJ-17,665 from Aspergillus ochraceus
- CJ-15,208, a Novel Kappa Opioid Receptor Antagonist from a Funguns, Ctenomyces serratus ATCC15502
- CJ-21, 164, a New D-Glucose-6-phosphate Phosphohydrolase Inhibitor Produced by a Fungus Chloridium sp.
- CJ-15,696 and Its Analogs, New Furopyridine Antibiotics from the Fungus Cladobotryum varium : Fermentation, Isolation, Structural Elucidation, Biotransformation and Antibacterial Activities
- Cytokine Production Inhibitors Produced by a Fungus, Oidiodendron griseum
- Novel Cytokine Production Inhibitors Produced by a Basidiomycete, Marasmiellus sp.
- CJ-13,981 and CJ-13,982, New Squalene Synthase Inhibitors
- New Quinolone Compounds from Pseudonocardia sp. with Selective and Potent Anti-Helicobacter pylori Activity: Taxonomy of Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities
- CJ-12, 373, a Novel Topoisomerase II Inhibitor: Fermentation, Isolaton, Atructure Elucidation and Biological Activities
- Novel Lactone Compounds from Mortierella verticillata that Induce the Human Low Density Lipoprotein Receptor Gene: Fermentation, Isolation, Structural Elucidation and Biological Activities
- CJ-12, 954 and Its Congeners, New Abti-Helicobacter pylori Compounds Produced by Phanerochaete velutina: Fermentation, Isolation, Structural Elucidation and Biological Activities
- Generation of Novel Rapamycin Structures by Microbial Manipulations
- CJ-12, 371 and CJ-12, 372, Two Novel DNA Gyrase Inhibitors Fermentation, Isolation, Structural Elucidation and Biological Activities
- Thielavins as Glucose-6-phosphatase (G6Pase) Inhibitors : Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities
- Erinacine E as a Kappa Opioid Receptor Agonist and Its New Analogs from a Basidiomycete, Hericium ramosum
- Novel Cephalosporins Having a Benzothiopyran Group 2.Synthesis and Biological Activity of Catecholic Benzothiopyran Group at the C-3 Side Chain
- Novel Cephalosporins Having a Benzothiopyran Group 1.Synthesis and Antibacterial Activity of Cephalosporin Derivatives Characterized by Novel C-3 Substituents of Benzothiopyran
- Regulation of Tumor Necrosis Factor-α Production by a Fungal Metabolite, PR 1388
- CJ-15,183, a New Inhibitor of Squalene Synthase Produced by a Fungus, Aspergillus aculeatus
- CJ-19,784, a New Antifungal Agent from a Fungus, Acanthostigmella sp.
- Pyripyropenes, Novel ACAT Inhibitors Produced by Aspergillus fumigatus III.Structure Elucidation of Pyripyropenes E to L
- Erinacines E, F, and G, Stimulators of Nerve Growth Factor (NGF)-Synthesis, from the Mycelia of Hericium erinaceum.
- Structural Requirement of Nociceptive Peptide Nociceptin : Structural Importance of C-Terminal Fragment for Receptor Recognition
- Structure-Activity Relationships of a Naturally Occurring Nociceptive Peptide, Nociceptin
- Effects of Substitution of Hydrophobic Amino Acids by Tryptophan on Receptor Binding and Biological Activity of Neuropeptide Nociceptin
- Synthesis and Antiangiogenic Activity of Staurosporine Derivatives
- Production of a New Methylated 6, 8a-Seco-6, 8a-deoxy Derivative of the Avermectins by a Transformant Strain of Streptomyces avermitilis
- Production of 6, 8a-Seco-6, 8a-deoxy Derivatives of Avermectins by a Mutant Strain of Streptomyces avermitilis
- Structural Requirements in Activation of Opioid Receptor-Like ORL1 Receptor by Nociceptin
- Dimerization and DNA Binding Facilitate α-Helix Formation of Max in Solution
- Chemical Modification and Structure-activity Relationships of Pyripyropenes 2. 1,11-Cyclic Analogs